Advances in the application of anti-inflammatory and liver-protecting drugs in treatment of autoimmune hepatitis
10.3969/j.issn.1001-5256.2017.03.042
- VernacularTitle:抗炎保肝药在自身免疫性肝炎治疗中的应用进展
- Author:
Hongxia ZHANG
;
Lu ZHOU
;
Bangmao WANG
- Keywords:
hepatitis,autoimmune;
drug therapy;
therapy;
review
- From:
Journal of Clinical Hepatology
2017;33(3):588-592
- CountryChina
- Language:Chinese
-
Abstract:
Autoimmune hepatitis (AIH) is the first liver disease which has proved responsive to gluc()orticoids,and the standard therapeutic method is hormone combined with azathioprine.Given that some patients fail to reach the standard of immunosuppressive therapy,and the long-term use of immunosuppressive therapy has many adverse effects,it is necessary to reasonably use anti-inflammatory and liver-protecting drugs to minimize the dose of immunosuppressants,control liver inflammation,reduce the damage of liver cells,and delay the progression of the disease.This paper reviews the advances in the application of anti-inflammatory and liver-protecting drugs in the treatment of AIH,in order to help clinicians make rational decisions.
